Protalix BioTherapeutics Inc (PLX)
1.21
+0.01
(+0.83%)
USD |
NYAM |
Apr 24, 16:00
1.215
0.00 (0.00%)
After-Hours: 20:00
Protalix BioTherapeutics Profit Margin (Quarterly): -57.64% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -57.64% |
| September 30, 2023 | -17.90% |
| June 30, 2023 | 55.14% |
| March 31, 2023 | -32.66% |
| December 31, 2022 | -43.40% |
| September 30, 2022 | -25.15% |
| June 30, 2022 | -60.94% |
| March 31, 2022 | -14.21% |
| December 31, 2021 | -77.99% |
| September 30, 2021 | -34.83% |
| June 30, 2021 | -174.9% |
| March 31, 2021 | -48.37% |
| December 31, 2020 | 2.04% |
| September 30, 2020 | -41.12% |
| June 30, 2020 | -37.84% |
| March 31, 2020 | 7.70% |
| December 31, 2019 | 1.64% |
| September 30, 2019 | -24.99% |
| June 30, 2019 | -63.22% |
| March 31, 2019 | -69.59% |
| December 31, 2018 | -52.49% |
| September 30, 2018 | -43.15% |
| June 30, 2018 | -174.9% |
| March 31, 2018 | -107.8% |
| December 31, 2017 | -309.1% |
| Date | Value |
|---|---|
| September 30, 2017 | -152.0% |
| June 30, 2017 | 7.08% |
| March 31, 2017 | -2.05K% |
| December 31, 2016 | -126.1% |
| September 30, 2016 | -156.1% |
| June 30, 2016 | -613.5% |
| March 31, 2016 | -1.27K% |
| December 31, 2015 | |
| September 30, 2015 | -285.9% |
| June 30, 2015 | -379.6% |
| March 31, 2015 | -353.0% |
| December 31, 2014 | 82.60% |
| September 30, 2014 | -216.1% |
| June 30, 2014 | -227.8% |
| March 31, 2014 | -99.49% |
| December 31, 2013 | |
| September 30, 2013 | -171.1% |
| June 30, 2013 | -223.1% |
| March 31, 2013 | -108.9% |
| December 31, 2012 | -20.58K% |
| September 30, 2012 | -101.7% |
| June 30, 2012 | 38.17% |
| March 31, 2012 | -158.4% |
| December 31, 2011 | -1.29K% |
| September 30, 2011 | -989.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-174.9%
Minimum
Jun 2021
55.14%
Maximum
Jun 2023
-36.24%
Average
-34.83%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
| Agenus Inc | -55.24% |
| InfuSystems Holdings Inc | 0.23% |
| Corbus Pharmaceuticals Holdings Inc | -- |
| AIM ImmunoTech Inc | -19.35K% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 41.07% |
| Return on Assets | 10.86% |
| Return on Invested Capital | 19.05% |
| Gross Profit Margin (Quarterly) | 15.54% |
| Operating Margin (Quarterly) | -53.55% |
| Return on Net Operating Assets | 23.86% |